Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Glucocorticoid-induced hyperglycemia.

Kwon S, Hermayer KL.

Am J Med Sci. 2013 Apr;345(4):274-7. doi: 10.1097/MAJ.0b013e31828a6a01. Review.

PMID:
23531958
2.

Glucocorticoid-induced hyperglycemia.

Clore JN, Thurby-Hay L.

Endocr Pract. 2009 Jul-Aug;15(5):469-74. doi: 10.4158/EP08331.RAR. Review.

PMID:
19454391
3.

Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis.

Liu XX, Zhu XM, Miao Q, Ye HY, Zhang ZY, Li YM.

Ann Nutr Metab. 2014;65(4):324-32. doi: 10.1159/000365892. Epub 2014 Nov 14.

PMID:
25402408
4.

Evaluation of the effects of exenatide administration in patients with type 2 diabetes with worsened glycemic control caused by glucocorticoid therapy.

Matsuo K, Nambu T, Matsuda Y, Kanai Y, Yonemitsu S, Muro S, Oki S.

Intern Med. 2013;52(1):89-95. Epub 2013 Jan 1.

5.

[Steroid-induced hyperglycemia, a common clinical problem in medicine without evidence-based guidelines].

Genolet P, Petite C, Petignat PA.

Rev Med Suisse. 2012 Apr 11;8(336):800-2, 804-5. French.

PMID:
22574414
6.

[Management and Treatment of Glucocorticoid-Induced Hyperglycemia].

Paredes S, Alves M.

Acta Med Port. 2016 Sep;29(9):556-563. doi: 10.20344/amp.7758. Epub 2016 Sep 30. Review. Portuguese.

7.

[Glucocorticoid-induced hyperglycemia - mechanisms, detection and therapeutic management].

Siegmund T.

MMW Fortschr Med. 2014 Nov 13;156 Spec no 2:90-2. Review. German. No abstract available.

PMID:
25552026
8.

Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases.

Uzu T, Harada T, Sakaguchi M, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A, Yamauchi A.

Nephron Clin Pract. 2007;105(2):c54-7. Epub 2006 Nov 29.

PMID:
17135768
9.

Risk factors for the development of glucocorticoid-induced diabetes mellitus.

Katsuyama T, Sada KE, Namba S, Watanabe H, Katsuyama E, Yamanari T, Wada J, Makino H.

Diabetes Res Clin Pract. 2015 May;108(2):273-9. doi: 10.1016/j.diabres.2015.02.010. Epub 2015 Feb 21.

PMID:
25765669
10.

Inpatient glucocorticoid use: beneficence vs non-maleficence.

Dhatariya K.

Br J Hosp Med (Lond). 2014 May;75(5):252-6. doi: 10.12968/hmed.2014.75.5.252. No abstract available.

PMID:
25040268
11.

Management of steroid-induced hyperglycemia in hospitalized patients with cancer: a review.

Brady VJ, Grimes D, Armstrong T, LoBiondo-Wood G.

Oncol Nurs Forum. 2014 Nov 1;41(6):E355-65. doi: 10.1188/14.ONF.E355-E365. Review.

PMID:
25355031
12.

Current smoking is an independent risk factor for new-onset diabetes mellitus during highdose glucocorticoid treatment.

Sugiyama T, Sugimoto T, Suzuki S, Sato Y, Tanaka T, Tatsuno I.

Int J Clin Pharmacol Ther. 2015 Aug;53(8):616-20. doi: 10.5414/CP202136.

PMID:
25997545
13.

Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies.

Healy SJ, Nagaraja HN, Alwan D, Dungan KM.

Endocrine. 2017 Apr;56(1):90-97. doi: 10.1007/s12020-016-1220-2. Epub 2017 Jan 6.

PMID:
28058528
14.

Drug selection and the management of corticosteroid-related diabetes mellitus.

Hoogwerf B, Danese RD.

Rheum Dis Clin North Am. 1999 Aug;25(3):489-505. Review.

PMID:
10467625
15.

Glucocorticoids and cardiovascular risk factors.

Strohmayer EA, Krakoff LR.

Endocrinol Metab Clin North Am. 2011 Jun;40(2):409-17, ix. doi: 10.1016/j.ecl.2011.01.011. Review.

PMID:
21565675
16.

Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes.

Baldwin D, Apel J.

Curr Diab Rep. 2013 Feb;13(1):114-20. doi: 10.1007/s11892-012-0339-7. Review.

PMID:
23090580
17.

Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients.

Burt MG, Drake SM, Aguilar-Loza NR, Esterman A, Stranks SN, Roberts GW.

Intern Med J. 2015 Mar;45(3):261-6. doi: 10.1111/imj.12680.

PMID:
25565560
18.

Glucocorticoid-induced hyperglycemia.

Perez A, Jansen-Chaparro S, Saigi I, Bernal-Lopez MR, MiƱambres I, Gomez-Huelgas R.

J Diabetes. 2014 Jan;6(1):9-20. doi: 10.1111/1753-0407.12090. Epub 2013 Oct 29. Review.

PMID:
24103089
19.

Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.

Rowbottom L, Stinson J, McDonald R, Emmenegger U, Cheng S, Lowe J, Giotis A, Cheon P, Chow R, Pasetka M, Thavarajah N, Pulenzas N, Chow E, DeAngelis C.

Ann Palliat Med. 2015 Apr;4(2):70-7. doi: 10.3978/j.issn.2224-5820.2015.04.07.

20.

Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases.

Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group.

Ophthalmology. 2012 Aug;119(8):1569-74. doi: 10.1016/j.ophtha.2012.01.043. Epub 2012 Apr 6.

Supplemental Content

Support Center